Aion Therapeutic Inc (TSE:AION) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Aion Therapeutic Inc. has been granted a Management Cease Trade Order by the BCSC, which gives them until October 28, 2024, to file necessary financial disclosures following the acquisition of Toppen Health. The company is working diligently to provide valuations and impairment tests required for the audit of its annual financial statements, and intends to meet the new deadline while issuing bi-weekly updates.
For further insights into TSE:AION stock, check out TipRanks’ Stock Analysis page.